SNDL Stock Price: Sundial Growers Inc drops for seventh straight session
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get all exclusive analysis, access our analysis and get Gold and signals alerts
Elevate your trading Journey.
UPGRADE- NASDAQ:SNDL fell by 3.78% during Tuesday’s trading session.
- Lawmakers have rejected a new cannabis bill on locally legalizing adult-use marijuana sales.
- Cannabis stocks continue to struggle on Tuesday as the losing streak continues.
NASDAQ:SNDL saw its recent winless streak extend to seven straight sessions as the once popular meme stock dips below its 200-day moving average. On Tuesday, shares of SNDL fell by a further 3.78% and closed the trading session at $0.65. Stocks pulled back on Tuesday after a bullish start to the week as all three major indices closed lower on rising fears of the impacts of the Fed’s rate hikes. Each index erased their gains from the previous session, with the Dow Jones dropping by 280 basis points, the S&P 500 shedding 1.26%, and the NASDAQ falling the hardest, losing 2.26% during the session.
Stay up to speed with hot stocks' news!
Washington DC lawmakers rejected a new bill that would legalize adult-use marijuana sales to adults who self-diagnose themselves for medical marijuana rather than requiring doctor’s recommendation. The Democrat-proposed bill was shot down by members from both parties, particularly the Republican side. The bill’s rejection comes on the heels of the MORE Act passing its vote last week on the floor of the House of Representatives. This Act is now awaiting a Senate vote to officially legalize cannabis on a federal level.
SNDL stock forecast
Sundial was not the only cannabis stock to struggle on Tuesday as most of the sector was trading below water. Other major brands like Tilray (NASDAQ:TLRY), Canopy Growth (NASDAQ:CGC), and Aurora Cannabis (NASDAQ:ACB) were also trading lower as the stocks extended their declines following the passing of the MORE Act vote.
- NASDAQ:SNDL fell by 3.78% during Tuesday’s trading session.
- Lawmakers have rejected a new cannabis bill on locally legalizing adult-use marijuana sales.
- Cannabis stocks continue to struggle on Tuesday as the losing streak continues.
NASDAQ:SNDL saw its recent winless streak extend to seven straight sessions as the once popular meme stock dips below its 200-day moving average. On Tuesday, shares of SNDL fell by a further 3.78% and closed the trading session at $0.65. Stocks pulled back on Tuesday after a bullish start to the week as all three major indices closed lower on rising fears of the impacts of the Fed’s rate hikes. Each index erased their gains from the previous session, with the Dow Jones dropping by 280 basis points, the S&P 500 shedding 1.26%, and the NASDAQ falling the hardest, losing 2.26% during the session.
Stay up to speed with hot stocks' news!
Washington DC lawmakers rejected a new bill that would legalize adult-use marijuana sales to adults who self-diagnose themselves for medical marijuana rather than requiring doctor’s recommendation. The Democrat-proposed bill was shot down by members from both parties, particularly the Republican side. The bill’s rejection comes on the heels of the MORE Act passing its vote last week on the floor of the House of Representatives. This Act is now awaiting a Senate vote to officially legalize cannabis on a federal level.
SNDL stock forecast
Sundial was not the only cannabis stock to struggle on Tuesday as most of the sector was trading below water. Other major brands like Tilray (NASDAQ:TLRY), Canopy Growth (NASDAQ:CGC), and Aurora Cannabis (NASDAQ:ACB) were also trading lower as the stocks extended their declines following the passing of the MORE Act vote.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.